Menelaos Pipis,Shawna M E Feely,James M Polke,Mariola Skorupinska,Laura Perez,Rosemary R Shy,Matilde Laura,Jasper M Morrow,Isabella Moroni,Chiara Pisciotta,Franco Taroni,Dragan Vujovic,Thomas E Lloyd,Gyula Acsadi,Sabrina W Yum,Richard A Lewis,Richard S Finkel,David N Herrmann,John W Day,Jun Li,Mario Saporta,Reza Sadjadi,David Walk,Joshua Burns,Francesco Muntoni,Sindhu Ramchandren,Rita Horvath,Nicholas E Johnson,Stephan Züchner,Davide Pareyson,Steven S Scherer,Alexander M Rossor,Michael E Shy,Mary M Reilly,for the Inherited Neuropathies Consortium - Rare Disease Clinical Research Network,Silvia Baratta,Paula Bray,Daniela Calabrese,Kayla Cornett,Gabrielle Donlevy,Katy Eichinger,Maria Foscan,Silvia Genitrini,Natalie Rose Grant,Tara Jones,Diana Lee,Brett A McCray,Stefania Magri,Manoj Menezes,Krista Mullen,Tina Nanji,Sara Nuzzo,Emanuela Pagliano,Roy Poh,Eun Park,Saba Sadaf,Paola Saveri,Carly Siskind,Janet E Sowden,Charlotte J Sumner,Simone Thomas,

Abstract:Abstract Mitofusin-2 (MFN2) is one of two ubiquitously expressed homologous proteins in eukaryote cells, playing a critical role in mitochondrial fusion. Mutations in MFN2 (most commonly autosomal dominant) cause Charcot-Marie-Tooth disease type 2A (CMT2A), the commonest axonal form of CMT, with significant allelic heterogeneity. Previous, moderately-sized, cross sectional genotype-phenotype studies of CMT2A have described the phenotypic spectrum of the disease, but longitudinal natural history studies are lacking. In this large multicentre prospective cohort study of 196 patients with dominant and autosomal recessive CMT2A, we present an in-depth genotype-phenotype study of the baseline characteristics of patients with CMT2A and longitudinal data (1–2 years) to describe the natural history. A childhood onset of autosomal dominant CMT2A is the most predictive marker of significant disease severity and is independent of the disease duration. When compared to adult onset autosomal dominant CMT2A, it is associated with significantly higher rates of use of ankle-foot orthoses, full-time use of wheelchair, dexterity difficulties and also has significantly higher CMT Examination Score (CMTESv2) and CMT Neuropathy Score (CMTNSv2) at initial assessment. Analysis of longitudinal data using the CMTESv2 and its Rasch-weighted counterpart, CMTESv2-R, show that over 1 year, the CMTESv2 increases significantly in autosomal dominant CMT2A (mean change 0.84 ± 2.42; two-tailed paired t-test P = 0.039). Furthermore, over 2 years both the CMTESv2 (mean change 0.97 ± 1.77; two-tailed paired t-test P = 0.003) and the CMTESv2-R (mean change 1.21 ± 2.52; two-tailed paired t-test P = 0.009) increase significantly with respective standardized response means of 0.55 and 0.48. In the paediatric CMT2A population (autosomal dominant and autosomal recessive CMT2A grouped together), the CMT Pediatric Scale increases significantly both over 1 year (mean change 2.24 ± 3.09; two-tailed paired t-test P = 0.009) and over 2 years (mean change 4.00 ± 3.79; two-tailed paired t-test P = 0.031) with respective standardized response means of 0.72 and 1.06. This cross-sectional and longitudinal study of the largest CMT2A cohort reported to date provides guidance for variant interpretation, informs prognosis and also provides natural history data that will guide clinical trial design.

Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

A Novel Mutation of the Membrane Metallo-Endopeptidase Gene Related to Late-Onset Hereditary Polyneuropathy: Case Report and Review of the Literature

A nonsense mutation in MME gene associates with autosomal recessive late-onset Charcot-Marie-Tooth disease

Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies

Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late-onset axonal neuropathies

Hereditary axonal neuropathy related to MME gene mutation in a family with fetomaternal alloimmune glomerulonephritis

The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME.

Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy

A Cross-Sectional Study of Nemaline Myopathy

Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study

Variants in MME are associated with autosomal-recessive distal hereditary motor neuropathy

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Early onset inherited peripheral neuropathies: the experience of a specialized referral center for genetic diagnosis achievement.

A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A

Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

A novel variant of biallelic MME gene associated with autosomal recessive late-onset distal hereditary motor neuropathy in Chinese families

[Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease]

Clinicopathological features in two families with MARS-related Charcot-Marie-Tooth disease

One Multilocus Genomic Variation Is Responsible for a Severe Charcot-Marie-Tooth Axonal Form